REIT - Healthcare Facilities
Compare Stocks
4 / 10Stock Comparison
CTRE vs CHCT vs SBRA vs GMRE
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
CTRE vs CHCT vs SBRA vs GMRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $8.79B | $500M | $5.17B | $94M |
| Revenue (TTM) | $324M | $122M | $813M | $148M |
| Net Income (TTM) | $261M | $6M | $156M | $2M |
| Gross Margin | 96.6% | 62.8% | 63.5% | 68.8% |
| Operating Margin | 55.7% | 31.3% | 29.0% | 24.9% |
| Forward P/E | 26.6x | 37.3x | 29.7x | 595.7x |
| Total Debt | $0.00 | $536M | $2.55B | $654M |
| Cash & Equiv. | $198M | $3M | $72M | $7M |
CTRE vs CHCT vs SBRA vs GMRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CareTrust REIT, Inc. (CTRE) | 100 | 211.9 | +111.9% |
| Community Healthcar… (CHCT) | 100 | 48.1 | -51.9% |
| Sabra Health Care R… (SBRA) | 100 | 152.3 | +52.3% |
| Global Medical REIT… (GMRE) | 100 | 64.6 | -35.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTRE vs CHCT vs SBRA vs GMRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTRE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 108.7%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- 270.6% 10Y total return vs GMRE's 308.1%
- 108.7% FFO/revenue growth vs GMRE's -1.8%
- Lower P/E (26.6x vs 595.7x)
CHCT plays a supporting role in this comparison — it may shine differently against other peers.
SBRA lags the leaders in this set but could rank higher in a more targeted comparison.
GMRE is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- Lower volatility, beta 0.48, current ratio 0.03x
- Beta 0.48, yield 63.5%, current ratio 0.03x
- 63.5% yield, 5-year raise streak, vs CHCT's 11.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.7% FFO/revenue growth vs GMRE's -1.8% | |
| Value | Lower P/E (26.6x vs 595.7x) | |
| Quality / Margins | 80.6% margin vs GMRE's 1.7% | |
| Stability / Safety | Beta 0.14 vs CHCT's 0.60 | |
| Dividends | 63.5% yield, 5-year raise streak, vs CHCT's 11.4% | |
| Momentum (1Y) | +38.7% vs GMRE's -0.3% | |
| Efficiency (ROA) | 5.1% ROA vs GMRE's 0.2%, ROIC 10.1% vs 2.0% |
CTRE vs CHCT vs SBRA vs GMRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CTRE vs CHCT vs SBRA vs GMRE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTRE leads in 3 of 6 categories
GMRE leads 1 • SBRA leads 1 • CHCT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SBRA is the larger business by revenue, generating $813M annually — 6.6x CHCT's $122M. CTRE is the more profitable business, keeping 80.6% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, CTRE holds the edge at +82.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $324M | $122M | $813M | $148M |
| EBITDAEarnings before interest/tax | $262M | $82M | $432M | $95M |
| Net IncomeAfter-tax profit | $261M | $6M | $156M | $2M |
| Free Cash FlowCash after capex | $334M | $60M | $367M | $19M |
| Gross MarginGross profit ÷ Revenue | +96.6% | +62.8% | +63.5% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +55.7% | +31.3% | +29.0% | +24.9% |
| Net MarginNet income ÷ Revenue | +80.6% | +5.0% | +19.2% | +1.7% |
| FCF MarginFCF ÷ Revenue | +103.2% | +49.4% | +45.1% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +82.4% | +4.8% | +20.8% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +66.7% | +124.4% | -5.9% | -166.2% |
Valuation Metrics
GMRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 25.1x trailing earnings, CTRE trades at a 89% valuation discount to CHCT's 226.2x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than SBRA's 17.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8.8B | $500M | $5.2B | $94M |
| Enterprise ValueMkt cap + debt − cash | $8.6B | $1.0B | $7.6B | $741M |
| Trailing P/EPrice ÷ TTM EPS | 25.15x | 226.23x | 32.03x | 115.29x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.56x | 37.26x | 29.71x | 595.67x |
| PEG RatioP/E ÷ EPS growth rate | 1.19x | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.27x | 16.19x | 16.96x | 8.35x |
| Price / SalesMarket cap ÷ Revenue | 18.46x | 4.13x | 6.67x | 0.68x |
| Price / BookPrice ÷ Book value/share | 1.99x | 1.10x | 1.77x | 0.17x |
| Price / FCFMarket cap ÷ FCF | 22.32x | 8.87x | 14.83x | — |
Profitability & Efficiency
CTRE leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
CTRE delivers a 6.5% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $0 for GMRE. SBRA carries lower financial leverage with a 0.90x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHCT's 1.25x. On the Piotroski fundamental quality scale (0–9), CTRE scores 6/9 vs GMRE's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.5% | +1.4% | +5.6% | +0.5% |
| ROA (TTM)Return on assets | +5.1% | +0.6% | +2.8% | +0.2% |
| ROICReturn on invested capital | +10.1% | +1.6% | +3.8% | +2.0% |
| ROCEReturn on capital employed | +11.0% | +2.8% | +5.2% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 4 |
| Debt / EquityFinancial leverage | — | 1.25x | 0.90x | 1.18x |
| Net DebtTotal debt minus cash | -$198M | $533M | $2.5B | $647M |
| Cash & Equiv.Liquid assets | $198M | $3M | $72M | $7M |
| Total DebtShort + long-term debt | $0 | $536M | $2.6B | $654M |
| Interest CoverageEBIT ÷ Interest expense | 10.76x | 1.15x | 2.40x | 1.14x |
Total Returns (Dividends Reinvested)
CTRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTRE five years ago would be worth $19,914 today (with dividends reinvested), compared to $5,416 for CHCT. Over the past 12 months, CTRE leads with a +38.7% total return vs GMRE's -0.3%. The 3-year compound annual growth rate (CAGR) favors CTRE at 29.6% vs CHCT's -14.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.8% | +10.2% | +8.6% | +6.9% |
| 1-Year ReturnPast 12 months | +38.7% | +14.1% | +21.3% | -0.3% |
| 3-Year ReturnCumulative with dividends | +117.7% | -36.6% | +112.3% | +5.6% |
| 5-Year ReturnCumulative with dividends | +99.1% | -45.8% | +52.4% | -19.8% |
| 10-Year ReturnCumulative with dividends | +270.6% | +78.5% | +54.1% | +308.1% |
| CAGR (3Y)Annualised 3-year return | +29.6% | -14.1% | +28.5% | +1.8% |
Risk & Volatility
SBRA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SBRA is the less volatile stock with a -0.06 beta — it tends to amplify market swings less than CHCT's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.3% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 0.60x | -0.06x | 0.48x |
| 52-Week HighHighest price in past year | $41.72 | $18.22 | $21.07 | $39.93 |
| 52-Week LowLowest price in past year | $27.72 | $13.23 | $17.08 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +94.6% | +96.1% | +97.3% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 53.5 | 59.4 | 52.5 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 230K | 2.1M | 115K |
Analyst Outlook
Evenly matched — CHCT and GMRE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTRE as "Buy", CHCT as "Hold", SBRA as "Hold", GMRE as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs 3.4% for SBRA (target: $21). For income investors, GMRE offers the higher dividend yield at 63.51% vs CTRE's 3.22%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $42.50 | $18.50 | $21.20 | $40.00 |
| # AnalystsCovering analysts | 19 | 16 | 29 | 22 |
| Dividend YieldAnnual dividend ÷ price | +3.2% | +11.4% | +5.8% | +63.5% |
| Dividend StreakConsecutive years of raises | 2 | 11 | 0 | 5 |
| Dividend / ShareAnnual DPS | $1.27 | $2.00 | $1.18 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.4% | 0.0% | 0.0% |
CTRE leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 1 (Valuation Metrics). 1 tied.
CTRE vs CHCT vs SBRA vs GMRE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTRE or CHCT or SBRA or GMRE a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 7% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). CareTrust REIT, Inc. (CTRE) offers the better valuation at 25. 1x trailing P/E (26. 6x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTRE or CHCT or SBRA or GMRE?
On trailing P/E, CareTrust REIT, Inc.
(CTRE) is the cheapest at 25. 1x versus Community Healthcare Trust Incorporated at 226. 2x. On forward P/E, CareTrust REIT, Inc. is actually cheaper at 26. 6x.
03Which is the better long-term investment — CTRE or CHCT or SBRA or GMRE?
Over the past 5 years, CareTrust REIT, Inc.
(CTRE) delivered a total return of +99. 1%, compared to -45. 8% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus SBRA's +54. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTRE or CHCT or SBRA or GMRE?
By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.
(SBRA) is the lower-risk stock at -0. 06β versus Community Healthcare Trust Incorporated's 0. 60β — meaning CHCT is approximately -1024% more volatile than SBRA relative to the S&P 500. On balance sheet safety, Sabra Health Care REIT, Inc. (SBRA) carries a lower debt/equity ratio of 90% versus 125% for Community Healthcare Trust Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — CTRE or CHCT or SBRA or GMRE?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 7% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Community Healthcare Trust Incorporated grew EPS 133. 7% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTRE or CHCT or SBRA or GMRE?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus 4. 2% for Community Healthcare Trust Incorporated — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 98. 7% versus 16. 7% for CHCT. At the gross margin level — before operating expenses — CTRE leads at 98. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTRE or CHCT or SBRA or GMRE more undervalued right now?
On forward earnings alone, CareTrust REIT, Inc.
(CTRE) trades at 26. 6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 569. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — CTRE or CHCT or SBRA or GMRE?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 3. 2% for CareTrust REIT, Inc. (CTRE).
09Is CTRE or CHCT or SBRA or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Sabra Health Care REIT, Inc.
(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +54. 1%, CHCT: +78. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTRE and CHCT and SBRA and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CTRE is a small-cap high-growth stock; CHCT is a small-cap income-oriented stock; SBRA is a small-cap income-oriented stock; GMRE is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.